The global AI in telehealth and telemedicine market is set to see a CAGR of 36.4% from 2024 to 2030, culminating in a forecasted valuation of $27.14bn, according to Markets & Markets.

The market was valued at $2.85bn in 2023 and stood at $4.22bn in 2024. It has experienced significant growth primarily driven by the geriatric and medically underserved predominantly rural population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of remote patient monitoring (RPM). The increasing use of wearables, apps and sensors for virtual care, the increasing shift towards outpatient care models, and the high use of telemedicine against infectious diseases and epidemics are significant opportunities in the market.

By application, the primary care segment commanded the most significant proportion of the AI in telemedicine market due to an increased need for day-to-day healthcare, such as check-ups, chronic condition management and preventive care, well-suited to AI implementation. These platforms leverage AI to automate symptom evaluation, virtual consultations and follow-ups to make healthcare more accessible and convenient for day-to-day health issues.

Organisations such as Hellocare in the USA provide a complete telehealth platform with AI-based options for primary care, including virtual patient observation and RPM. These increase patient engagement and simplify care delivery. Furthermore, CVS Health in the USA provides virtual primary care with personalised digital healthcare services, letting users access and manage their health remotely.

By function, the RPM segment is expected to see the fastest-growing use of AI in telehealth by function due to the increasing number of chronic diseases including diabetes, hypertension and CVDs that need constant monitoring and management. RPM systems constantly monitor patient health data, eliminating the need for many hospital visits and improving patient outcomes.

Many healthcare facilities, such as Mayo Clinic in the USA, offer RPM systems to reduce readmission rates. Earlier this year Taiwan’s Industrial Technology Research Institute (ITRI) introduced AI-based RPM devices that were developed in partnership with local company StreamTeck to detect patient vitals such as body temperature, heart rate and blood pressure.

By geography, North America accounted for the largest market share due to the region’s modern healthcare infrastructure, the widespread use of technologies and extensive governmental support. The USA, especially, has adopted favourable reimbursement policies and regulatory mandates, including those from the Centers for Medicare & Medicaid Services (CMS), to increase telehealth access and RPM technology. Favourable government initiatives have also propelled market growth. In 2023, the American Telemedicine Association published a plan to advance the safe, appropriate and responsible use of AI in healthcare that enhances patient and provider trust, safety, and the efficacy of AI adoption as a tool in healthcare.

Numerous US companies provide AI-based telehealth and telemedicine. For example, in 2024, Zoom Communications partnered with Suki AI to implement AI-powered voice tools within its telehealth services to improve clinical documentation functionalities.

Prominent players in the telehealth and telemedicine market include Philips (Netherlands), Medtronic (Ireland), GE Healthcare (USA), Epic Systems (USA), Oracle (USA), Doximity (USA), Teladoc Health (USA), American Well (USA), Siemens Healthineers (Germany) and Cisco (USA).

For more on the report, see www.marketsandmarkets.com/Market-Reports/ai-in-telehealth-telemedicine-market-108525984.html.